U.S. FDA classifies Aurobindo arm’s North Carolina plant VAI
· thehindu.com
Aurobindo Pharma’s North Carolina plant receives U.S. FDA Voluntary Action Indicated classification, allowing progress on inhaler applications.
Aurobindo Pharma on Monday (August 17, 2026) said the U.S. Food and Drug Administration (U.S. FDA) has issued Establishment Inspection Report (EIR) to subsidiar...